Mind Medicine Stock Market Value
| MNMD Stock | USD 7.09 0.43 5.72% |
| Symbol | Mind |
Mind Medicine Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.71) | Return On Assets (0.25) | Return On Equity (0.55) |
The market value of Mind Medicine is measured differently than its book value, which is the value of Mind that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mind Medicine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mind Medicine's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mind Medicine.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Mind Medicine on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Mind Medicine or generate 0.0% return on investment in Mind Medicine over 30 days. Mind Medicine is related to or competes with Cybin, Seelos Therapeutics, GH Research, ATAI Life, Bio Path, Vaccinex, and Eliem Therapeutics. Mind Medicine Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders ... More
Mind Medicine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mind Medicine's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mind Medicine upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.08 | |||
| Information Ratio | 0.0321 | |||
| Maximum Drawdown | 24.75 | |||
| Value At Risk | (6.71) | |||
| Potential Upside | 9.76 |
Mind Medicine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mind Medicine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mind Medicine's standard deviation. In reality, there are many statistical measures that can use Mind Medicine historical prices to predict the future Mind Medicine's volatility.| Risk Adjusted Performance | 0.0506 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0369 | |||
| Treynor Ratio | 0.0804 |
Mind Medicine Backtested Returns
Mind Medicine appears to be moderately volatile, given 3 months investment horizon. Mind Medicine has Sharpe Ratio of 0.0719, which conveys that the firm had a 0.0719% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Mind Medicine, which you can use to evaluate the volatility of the firm. Please exercise Mind Medicine's Risk Adjusted Performance of 0.0506, mean deviation of 3.53, and Downside Deviation of 4.08 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Mind Medicine holds a performance score of 5. The company secures a Beta (Market Risk) of 3.11, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mind Medicine will likely underperform. Please check Mind Medicine's treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to make a quick decision on whether Mind Medicine's current price movements will revert.
Auto-correlation | -0.31 |
Poor reverse predictability
Mind Medicine has poor reverse predictability. Overlapping area represents the amount of predictability between Mind Medicine time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mind Medicine price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current Mind Medicine price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 0.43 |
Mind Medicine lagged returns against current returns
Autocorrelation, which is Mind Medicine stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mind Medicine's stock expected returns. We can calculate the autocorrelation of Mind Medicine returns to help us make a trade decision. For example, suppose you find that Mind Medicine has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mind Medicine regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mind Medicine stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mind Medicine stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mind Medicine stock over time.
Current vs Lagged Prices |
| Timeline |
Mind Medicine Lagged Returns
When evaluating Mind Medicine's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mind Medicine stock have on its future price. Mind Medicine autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mind Medicine autocorrelation shows the relationship between Mind Medicine stock current value and its past values and can show if there is a momentum factor associated with investing in Mind Medicine.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mind Medicine is a strong investment it is important to analyze Mind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mind Medicine's future performance. For an informed investment choice regarding Mind Stock, refer to the following important reports:Check out Mind Medicine Correlation, Mind Medicine Volatility and Mind Medicine Alpha and Beta module to complement your research on Mind Medicine. For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Mind Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.